<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Candida vulvovaginitis: Clinical manifestations and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Candida vulvovaginitis: Clinical manifestations and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Candida vulvovaginitis: Clinical manifestations and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jack D Sobel, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Caroline Mitchell, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert L Barbieri, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carol A Kauffman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 25, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvovaginal candidiasis is one of the most common causes of vulvovaginal itching and discharge. The disorder is characterized by inflammation in the setting of
         <em>
          Candida
         </em>
         species and results in the common vaginitis symptoms of itching and erythema. While
         <em>
          Candida
         </em>
         vulvovaginitis is frequently self-diagnosed, office diagnosis with microscopy is preferred.
        </p>
        <p>
         This topic will discuss the clinical presentation, diagnostic approach, and diagnosis of vulvovaginal candidiasis. Related topics on the treatment of vulvovaginal candidiasis and vaginitis in general are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115170.html" rel="external">
          "Candida vulvovaginitis in adults: Treatment of acute infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5453.html" rel="external">
          "Trichomoniasis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender diverse individuals.
        </p>
        <p class="headingAnchor" id="H2627724520">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvovaginal candidiasis refers to a disorder characterized by signs and symptoms of vulvovaginal inflammation in the presence of
         <em>
          Candida
         </em>
         species. Identification of vulvovaginal
         <em>
          Candida
         </em>
         alone is not indicative of disease, as
         <em>
          Candida
         </em>
         species are part of the normal flora of approximately 25 percent of women [
         <a href="#rid1">
          1
         </a>
         ]. In contrast to oropharyngeal candidiasis, it is generally not considered an opportunistic infection. Vulvovaginal candidiasis is not considered a sexually transmitted disease.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvovaginal candidiasis is the second most common cause of vaginitis symptoms (after bacterial vaginosis) and accounts for approximately one-third of vaginitis cases [
         <a href="#rid2">
          2
         </a>
         ]. The prevalence of vulvovaginal candidiasis is difficult to determine because:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Candida
         </em>
         species, without inflammation, can be identified in the lower genital tract in 10 to 20 percent of healthy women in the reproductive age group, 6 to 7 percent of menopausal women, and 3 to 6 percent of prepubertal girls [
         <a href="#rid3">
          3,4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The widespread use of over-the-counter antifungal drugs makes epidemiologic studies difficult to perform.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The clinical diagnosis is often based on symptoms and not confirmed by microscopic examination or culture.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As many as one-half of clinically diagnosed women may have another condition [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Culture performed without clinical correlation is likely to overestimate the prevalence of disease.
        </p>
        <p>
        </p>
        <p>
         In surveys, the prevalence of vulvovaginal candidiasis is highest among women in their reproductive years: 55 percent of female university students report having had at least one health care provider-diagnosed episode by age 25 years, 29 to 49 percent of premenopausal women report having had at least one lifetime episode, and 9 percent of women report having had four or more infections in a 12-month period (ie, recurrent vulvovaginal candidiasis [RVVC]) [
         <a href="#rid6">
          6,7
         </a>
         ]. In a separate study, in women with an initial infection, the probability of RVVC was 10 percent by age 25 years and 25 percent by age 50 years [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/141182.html" rel="external">
          "Candida vulvovaginitis in adults: Recurrent infection"
         </a>
         .)
        </p>
        <p>
         The incidence of a single or sporadic infection increases with age up to menopause and is higher in African-American women than in other ethnic groups. The disorder is uncommon in postmenopausal women unless they are taking estrogen therapy. It is also uncommon in prepubertal girls, in whom it is frequently overdiagnosed.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          MICROBIOLOGY AND PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Candida albicans
         </em>
         is responsible for 80 to 92 percent of episodes of vulvovaginal candidiasis in the United States [
         <a href="#rid8">
          8,9
         </a>
         ], and
         <em>
          Candida glabrata
         </em>
         accounts for almost all of the remainder [
         <a href="#rid10">
          10
         </a>
         ]. Some, but not all, investigators have reported an increasing frequency of nonalbicans species, particularly
         <em>
          C. glabrata
         </em>
         [
         <a href="#rid11">
          11,12
         </a>
         ], possibly due to widespread use of over-the-counter drugs, long-term use of suppressive azoles, and the use of short courses of antifungal drugs.
        </p>
        <p>
         All
         <em>
          Candida
         </em>
         species produce similar vulvovaginal symptoms, although the severity of symptoms is milder with
         <em>
          C. glabrata
         </em>
         and
         <em>
          C. parapsilosis
         </em>
         .
         <em>
          Candida
         </em>
         organisms probably access the vagina via migration from the rectum across the perianal area [
         <a href="#rid13">
          13
         </a>
         ]; cultures of the gastrointestinal tract and vagina often show identical
         <em>
          Candida
         </em>
         species. Less commonly, the source of infection is sexual or relapse from a vaginal reservoir. In contrast to bacterial vaginosis, vulvovaginal candidiasis is not associated with a reduction in vaginal lactobacilli [
         <a href="#rid14">
          14-17
         </a>
         ].
        </p>
        <p>
         Symptomatic disease is associated with an overgrowth of the organism and penetration of superficial epithelial cells [
         <a href="#rid18">
          18-21
         </a>
         ]. The mechanism by which
         <em>
          Candida
         </em>
         species transform from asymptomatic colonization to an invasive form causing symptomatic vulvovaginal disease is complex, involving host inflammatory responses and yeast virulence factors. One study comparing histologic specimens from women with confirmed vulvovaginal candidiasis, women without infection, and women with active bacterial vaginosis has reported co-invasion with
         <em>
          Gardnerella
         </em>
         or
         <a class="drug drug_general" data-topicid="9541" href="/z/d/drug information/9541.html" rel="external">
          Lactobacillus
         </a>
         species organisms in women with
         <em>
          Candida
         </em>
         infection but absence of a biofilm (in contrast with bacterial vaginosis) [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis", section on 'Pathogenesis and microbiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         While sporadic attacks of vulvovaginal candidiasis often occur without an identifiable precipitating factor, some risk factors have been identified [
         <a href="#rid22">
          22,23
         </a>
         ]:
        </p>
        <p class="headingAnchor" id="H2723315511">
         <span class="h2">
          Demonstrated impact
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some diseases, endocrine changes, and medication use predispose to candida infections.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diabetes mellitus
         </strong>
         – Women with diabetes mellitus who have poor glycemic control are more prone to vulvovaginal candidiasis than euglycemic women [
         <a href="#rid24">
          24,25
         </a>
         ]. In particular, women with type 2 diabetes appear prone to nonalbicans
         <em>
          Candida
         </em>
         species [
         <a href="#rid26">
          26
         </a>
         ]. Treatment with sodium glucose cotransporter 2 inhibitors may increase the risk for vulvovaginal candidiasis [
         <a href="#rid27">
          27,28
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2739.html" rel="external">
          "Susceptibility to infections in persons with diabetes mellitus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotic use
         </strong>
         – Use of broad-spectrum antibiotics significantly increases the risk of developing vulvovaginal candidiasis [
         <a href="#rid29">
          29
         </a>
         ]. As many as one-quarter to one-third of women develop the disorder during or after taking these antibiotics because inhibition of normal bacterial flora favors growth of potential fungal pathogens, such as
         <em>
          Candida
         </em>
         . Administration of
         <a class="drug drug_general" data-topicid="9541" href="/z/d/drug information/9541.html" rel="external">
          Lactobacillus
         </a>
         (oral or vaginal) during and for four days after antibiotic therapy does not prevent post-antibiotic vulvovaginitis [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased estrogen levels
         </strong>
         – Vulvovaginal candidiasis appears to occur more often in the setting of increased estrogen levels, such as pregnancy and postmenopausal estrogen therapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunosuppression
         </strong>
         – Candidal infections are more common in immunosuppressed patients, such as those taking glucocorticoids or other immunosuppressive drugs, or with human immunodeficiency virus (HIV) infection [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3986.html" rel="external">
          "Glucocorticoid effects on the immune system"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic
         </strong>
         – An analysis of whole exome sequencing from 160 European women with recurrent vulvovaginal candidiasis (RVVC) and 175 controls from the same regions demonstrated an association with polymorphisms in the
         <em>
          SIGLEC15
         </em>
         gene, which produces a cell surface protein found on macrophages and dendritic cells [
         <a href="#rid32">
          32
         </a>
         ]. Previous studies that evaluated known pathways identified associations between RVVC and polymorphisms in the
         <em>
          TLR2
         </em>
         [
         <a href="#rid33">
          33
         </a>
         ] and mannose-binding lectin genes [
         <a href="#rid34">
          34
         </a>
         ]. Although these genetic variations are not modifiable risk factors, in the future, they may help guide treatment or prevention strategies.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2756463289">
         <span class="h2">
          Unclear impact
         </span>
         <span class="headingEndMark">
          —
         </span>
         The role of various contraceptive devices, sexual behaviors, and diet on the risk of
         <em>
          Candida
         </em>
         vulvovaginitis is less clear.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Combined
         </strong>
         <strong>
          oral contraceptives (COC)
         </strong>
         – A 2013 systematic review of the literature found that, of 12 studies including more than 200 women, 7 demonstrated a significant association between COC use and prevalent or incident candidiasis, 2 found an association that was not statistically significant, and 3 found no association or a lower risk of candidiasis. However, the authors note that among the three highest quality studies, results were evenly split: one showed an increased risk in COC users, one showed no association, and one showed reduced risk in COC users [
         <a href="#rid35">
          35
         </a>
         ]. Since that review, in one study of over 1000 HIV serodiscordant couples in Zambia, COC use was associated with lower risk for candidiasis, though pregnancy was associated with a higher risk [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contraceptive devices
         </strong>
         – Vaginal sponges, diaphragms, and intrauterine devices (IUDs) have been associated with vulvovaginal candidiasis, but not consistently. At least two studies have suggested that recurrent
         <em>
          Candida
         </em>
         vulvovaginitis in IUD users may be related to the ability of some species to attach to the IUD and form a biofilm rather than related to an intrinsic property of the IUD itself [
         <a href="#rid37">
          37,38
         </a>
         ]. Spermicides are not associated with
         <em>
          Candida
         </em>
         infection. (See
         <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">
          "Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5419.html" rel="external">
          "Intrauterine contraception: Candidates and device selection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sexual behavior
         </strong>
         – Vulvovaginal candidiasis is not traditionally considered a sexually transmitted disease since it occurs in celibate women and since
         <em>
          Candida
         </em>
         species are considered part of the normal vaginal flora. This does not mean that sexual transmission of
         <em>
          Candida
         </em>
         does not occur or that vulvovaginal candidiasis is not associated with sexual activity. For example, an increased frequency of vulvovaginal candidiasis has been reported at the time most women begin regular sexual activity [
         <a href="#rid6">
          6,22,39
         </a>
         ]. In addition, partners of infected women are four times more likely to be colonized than partners of uninfected women, and colonization is often the same strain in both partners. However, the number of episodes of vulvovaginal candidiasis a woman experiences does not appear to be related to her lifetime number of sexual partners or the frequency of coitus [
         <a href="#rid22">
          22,40,41
         </a>
         ]. Women who exclusively have sex with women do not appear to have an increased risk of vulvovaginal infection [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The type of sex may be a factor. Infection may be linked to orogenital and, less commonly, anogenital sex. Evidence of a link between vulvovaginal candidiasis and hygienic habits (eg, douching, use of tampons/menstrual pads) or wearing tight or synthetic clothing is weak and conflicting [
         <a href="#rid22">
          22,43-50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diet
         </strong>
         – There are few high-quality data examining the link between vulvovaginal candidiasis and diet. Most studies are cross-sectional and have high to moderate risk of bias. A few small studies show no association between consumption of yogurt or fermented dairy products and risk for Candida vulvovaginitis [
         <a href="#rid50">
          50,51
         </a>
         ]. Two studies demonstrate higher dairy consumption among women with symptomatic vulvovaginal yeast infection, though this may be due to the common practice of eating yogurt to try and reduce recurrent infections [
         <a href="#rid43">
          43,52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H3916109009">
         <span class="h2">
          Symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvar pruritus is the dominant feature of vulvovaginal candidiasis [
         <a href="#rid10">
          10,19,53-55
         </a>
         ]. Vulvar burning, soreness, and irritation are also common and can be accompanied by dysuria (typically perceived to be external or vulvar rather than urethral) or dyspareunia. Symptoms are often worse during the week prior to menses [
         <a href="#rid55">
          55
         </a>
         ]. The intensity of signs and symptoms varies from mild to severe, except among women with
         <em>
          C. glabrata
         </em>
         or
         <em>
          C. parapsilosis
         </em>
         infection, who tend to have mild or minimal clinical findings [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4116688369">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physical examination of the external genitalia, vagina, and cervix often reveals erythema of the vulva and vaginal mucosa and vulvar edema  (
         <a class="graphic graphic_picture graphicRef115181" href="/z/d/graphic/115181.html" rel="external">
          picture 1
         </a>
         ). Vulvar excoriation and fissures are present in approximately one-quarter of patients. However, these changes reflect generalized inflammation and are not necessarily specific to
         <em>
          Candida
         </em>
         infections. There can be little or no discharge; when present, it is classically white, thick, adherent to the vaginal sidewalls, and clumpy (curd-like or cottage cheese-like) with no or minimal odor. However, the discharge may be thin and loose, watery, homogeneous, and indistinguishable from that in other types of vaginitis. The cervix usually appears normal.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          DIAGNOSTIC APPROACH
         </span>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Clinical evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         At the time of physical examination, a sample of vaginal discharge is collected for testing. Office-based tests include pH and microscopy or point-of-care molecular tests. Office-based tests provide immediate results. Alternately, the vaginal discharge can be sent for laboratory testing with molecular tests, typically nucleic acid amplification tests (NAATs). Laboratory tests may take longer for test results but have a higher accuracy [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3930368424">
         <span class="h3">
          Vaginal pH and microscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The office evaluation consists of swabbing the vaginal sidewall and discharge, assessing the vaginal pH, and performing microscopy [
         <a href="#rid58">
          58
         </a>
         ]. The vaginal pH in women with
         <em>
          Candida
         </em>
         infection is typically normal (4 to 4.5), which distinguishes candidiasis from trichomoniasis or bacterial vaginosis  (
         <a class="graphic graphic_table graphicRef68759" href="/z/d/graphic/68759.html" rel="external">
          table 1
         </a>
         ). In mixed infections,
         <em>
          Candida
         </em>
         can be seen at higher pH levels.
         <em>
          Candida
         </em>
         species can be seen on a wet mount of the discharge; adding 10 percent potassium hydroxide destroys the cellular elements and facilitates recognition of budding yeast, pseudohyphae, and hyphae  (
         <a class="graphic graphic_picture graphicRef59030" href="/z/d/graphic/59030.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef61326" href="/z/d/graphic/61326.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef53369" href="/z/d/graphic/53369.html" rel="external">
          picture 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef80723" href="/z/d/graphic/80723.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef76924" href="/z/d/graphic/76924.html" rel="external">
          picture 6
         </a>
         and
         <a class="graphic graphic_picture graphicRef61641" href="/z/d/graphic/61641.html" rel="external">
          picture 7
         </a>
         ) [
         <a href="#rid59">
          59
         </a>
         ]. Use of Swartz-Lamkins fungal stain (potassium hydroxide, a surfactant, and blue dye) may facilitate diagnosis by staining the
         <em>
          Candida
         </em>
         organisms blue so they are easier to identify [
         <a href="#rid60">
          60
         </a>
         ]. However, microscopy is negative in up to 50 percent of patients with culture-confirmed vulvovaginal candidiasis [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Microscopy is also important for looking for clue cells or motile trichomonads, which indicate bacterial vaginosis and trichomoniasis, respectively, as alternative diagnoses, coinfection, or mixed vaginitis [
         <a href="#rid61">
          61
         </a>
         ]. The general diagnostic approach to women with vaginal complaints is reviewed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5453.html" rel="external">
          "Trichomoniasis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3828943">
         <span class="h3">
          Molecular and other tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data supporting point-of-care tests for
         <em>
          Candida
         </em>
         are limited [
         <a href="#rid62">
          62-68
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A DNA probe test performed in a centralized laboratory offers results comparable to culture with results available in several hours, but no speciation (Affirm VPIII).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Polymerase chain reaction (PCR) methods have high sensitivity and specificity and a shorter turn-around time than culture [
         <a href="#rid69">
          69-72
         </a>
         ] but are costly and offer no proven clinical benefit over culture in symptomatic women [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A molecular test (BD MAX) that assays the vaginal microbiome for evidence of bacterial vaginosis, vaginal candidiasis, and trichomonas has shown promise in initial clinical studies, with a sensitivity for
         <em>
          Candida
         </em>
         species group of 90 percent (95% CI 88.1-93.1 percent) and specificity of 94.1 percent (95% CI 92.6-95.4 percent) compared with culture. Sensitivity for
         <em>
          C. glabrata
         </em>
         was lower, at 75.9 percent (95% CI 57.9-87.8 percent), but specificity was higher at 99.7 percent (99.3-99.9 percent). Another assay approved by the US Food and Drug Administration, the Aptima CV/TV, had similar sensitivity and specificity for the
         <em>
          Candida
         </em>
         species group (sensitivity 91.7 percent, specificity 94.9 percent) and higher sensitivity for
         <em>
          C. glabrata
         </em>
         (sensitivity 84.7 percent, specificity 99.1 percent) [
         <a href="#rid57">
          57,73
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pap smear is positive in 25 percent of patients with culture-positive, symptomatic vulvovaginal candidiasis [
         <a href="#rid10">
          10
         </a>
         ]. It is insensitive because the cells are derived from the cervix, which is not affected by
         <em>
          Candida
         </em>
         vaginitis. (See
         <a class="medical medical_review" href="/z/d/html/115170.html" rel="external">
          "Candida vulvovaginitis in adults: Treatment of acute infection", section on 'Unique populations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4107292062">
         <span class="h3">
          Limited role of culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Culture is not typically required for the routine diagnosis of vulvovaginal candidiasis because vaginal pH and microscopy are reliable tests and because yeast are normal colonizers of the vagina (ie, a culture that confirms yeast may not reflect actual infection).
        </p>
        <p>
         We obtain a vaginal culture in:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with clinical features of vulvovaginal candidiasis, normal vaginal pH, and no pathogens (yeast, clue cells, trichomonads) visible on microscopy. A positive culture in these patients confirms the diagnosis and reveals the species of
         <em>
          Candida
         </em>
         , thus avoiding empiric, unindicated, or incorrect therapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with persistent or recurrent symptoms because many of these patients have nonalbicans infections and/or infections that are resistant to azoles.
         <em>
          C. glabrata
         </em>
         is not easily recognized on microscopy because it does not form hyphae or pseudohyphae [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115170.html" rel="external">
          "Candida vulvovaginitis in adults: Treatment of acute infection", section on 'Non-albicans Candida species'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/141182.html" rel="external">
          "Candida vulvovaginitis in adults: Recurrent infection", section on 'Azole-resistant infection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         To perform a culture, a vaginal sample is obtained from the lateral wall using a cotton-tipped swab and inoculated onto Sabouraud agar, Nickerson medium, or Microstix-Candida medium; these media perform equally well [
         <a href="#rid10">
          10
         </a>
         ]. Culture for
         <em>
          Candida
         </em>
         does not require quantification of in vitro colony count. Speciation of
         <em>
          Candida
         </em>
         is not essential for primary diagnostic testing, as most isolates are
         <em>
          C. albicans
         </em>
         ; however, species identification is essential in refractory and recurrent disease.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Self-diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Self-diagnosis of vulvovaginal candidiasis is frequently inaccurate and should be discouraged [
         <a href="#rid58">
          58,74,75
         </a>
         ]. In a study that administered a questionnaire to 600 women to assess their knowledge of the symptoms and signs of vulvovaginal candidiasis (and other infections) after reading classic case scenarios, only 11 percent of women without a previous diagnosis of vulvovaginal candidiasis correctly diagnosed this infection [
         <a href="#rid74">
          74
         </a>
         ]. Women who had had a prior episode were more often correct (35 percent) but were likely to use over-the-counter drugs inappropriately to treat other, potentially more serious, gynecologic disorders.
        </p>
        <p>
         In another report, the actual diagnoses in 95 women who self-diagnosed vulvovaginal candidiasis were vulvovaginal candidiasis (34 percent), bacterial vaginosis (19 percent), mixed vaginitis (21 percent), normal flora (14 percent),
         <em>
          Trichomonas
         </em>
         vaginitis (2 percent), and other (11 percent) [
         <a href="#rid75">
          75
         </a>
         ]. Women with a previous episode of vulvovaginal candidiasis and those who read the package insert for their over-the-counter medication were not more accurate in making a diagnosis than other women.
        </p>
        <p>
         Some consequences of misdiagnosis and inappropriate therapy include a delay in correct diagnosis and treatment, wasted monetary expenditure, and precipitation of vulvar dermatitis.
        </p>
        <p class="headingAnchor" id="H1452438587">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of vulvovaginal candidiasis is based upon the presence of
         <em>
          Candida
         </em>
         on wet mount (preferred), Gram stain, culture, or molecular testing of vaginal discharge in a woman with characteristic clinical findings (eg, vulvovaginal pruritus, burning, erythema, edema, and/or curd-like discharge attached to the vaginal sidewall) and no other pathogens to account for her symptoms [
         <a href="#rid58">
          58
         </a>
         ]. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
         As none of the clinical manifestations of vulvovaginal candidiasis are pathognomonic, suspected clinical diagnosis should always be confirmed by laboratory methods (ie, microscopy, Gram stain, or culture). Once the diagnosis is confirmed, the infection is then categorized as complicated or uncomplicated to facilitate treatment  (
         <a class="graphic graphic_table graphicRef62038" href="/z/d/graphic/62038.html" rel="external">
          table 2
         </a>
         ). Treatment of
         <em>
          Candida
         </em>
         vulvovaginitis is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/115170.html" rel="external">
          "Candida vulvovaginitis in adults: Treatment of acute infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H86369992">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Importantly, although vulvar pruritus is a cardinal symptom of the disorder, less than 50 percent of women with genital pruritus have vulvovaginitis candidiasis [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Normal vaginal pH
         </strong>
         – Other conditions considered in the differential diagnosis of vulvovaginitis with normal vaginal pH include hypersensitivity reactions, allergic or chemical reactions, contact dermatitis, neuropathic itch, and inflammatory dermatoses (eg, lichen sclerosus and lichen planus) [
         <a href="#rid77">
          77
         </a>
         ]. Recognizing local adverse reactions to topical agents avoids the prescribing of additional agents that can worsen symptoms. These conditions are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5563.html" rel="external">
          "Vulvar dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, mechanical irritation due to insufficient lubrication during coitus can also result in vaginal discomfort.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Elevated vaginal pH
         </strong>
         – If vaginal pH exceeds 4.5 or excess white cells are present, mixed infection with bacterial vaginosis or trichomoniasis may be present. Mixed infection (≥2 pathogens and all are symptomatic) is estimated to occur in &lt;5 percent of patients; coinfection (≥2 pathogens but some are not symptomatic) is more common: 20 to 30 percent of women with bacterial vaginosis are coinfected with
         <em>
          Candida
         </em>
         species [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5453.html" rel="external">
          "Trichomoniasis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When significant white cells are present, desquamative inflammatory vaginitis should also be considered in the differential [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5454.html" rel="external">
          "Desquamative inflammatory vaginitis (DIV)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1420757163">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111629.html" rel="external">
          "Society guideline links: Gynecologic infectious diseases (non-sexually transmitted)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15467.html" rel="external">
          "Patient education: Vulvovaginal yeast infection (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83970.html" rel="external">
          "Patient education: Vulvar itching (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/8402.html" rel="external">
          "Patient education: Vaginal yeast infection (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         –
         <em>
          Candida
         </em>
         is considered part of the normal vaginal flora, but overgrowth of the organism can result in vulvovaginitis.
         <em>
          Candida albicans
         </em>
         accounts for 80 to 92 percent of episodes of vulvovaginal candidiasis;
         <em>
          Candida glabrata
         </em>
         is the next most common species. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Microbiology and pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – Risk factors for
         <em>
          Candida
         </em>
         vulvovaginitis include diabetes mellitus, antibiotic use, elevated estrogen levels, and immunocompromise. However, many women with sporadic or recurrent infection have no identifiable risk factors. (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Vulvar pruritus is the dominant symptom. Vulvar burning, soreness, and irritation are common and may result in dysuria and dyspareunia. The vulva and vagina appear erythematous, and vulvar excoriation and fissures may be present. There is often little or no discharge; when present, it is classically white, thick, adherent, and clumpy (curd-like or cottage cheese-like) with no or minimal odor. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of vulvovaginal candidiasis is based on the presence of
         <em>
          Candida
         </em>
         on wet mount (preferred), Gram stain, or culture of vaginal discharge in a woman with characteristic clinical findings. (See
         <a class="local">
          'Clinical evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of vaginal culture
         </strong>
         – Culture is not necessary for diagnosis if microscopy shows yeast but should be obtained in some individuals (see
         <a class="local">
          'Limited role of culture'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Individuals with clinical features of vulvovaginal candidiasis, normal vaginal pH, and negative microscopy.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Individuals with persistent or recurrent symptoms because many of these women have nonalbicans infection resistant to azoles.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of vulvar pruritus and erythema varies based on the vaginal pH of the affected women. For women with a normal pH, possible etiologies include hypersensitivity reactions, allergic or chemical reactions, and contact dermatitis. For women with vaginal pH above 4.5, or if excessive white blood cells are present, they can have mixed infection with bacterial vaginosis or trichomoniasis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Gardella C, Eckert LO, Lentz GM. Genital tract infections. In: Comprehensive Gynecology, 7th ed, Lobo RA, Gershenson DM, Lentz GM, Valea FA (Eds), Elsevier, Philadelphia 2017. p.542.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldacre MJ, Watt B, Loudon N, et al. Vaginal microbial flora in normal young women. Br Med J 1979; 1:1450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tibaldi C, Cappello N, Latino MA, et al. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: Risk factors and rates of occurrence. Clin Microbiol Infect 2009; 15:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA 1984; 251:620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health 1995; 85:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foxman B, Muraglia R, Dietz JP, et al. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 2013; 17:340.
          </a>
         </li>
         <li class="breakAll">
          Odds FC. Candidosis of the genitalia. In: Candida and Candidosis: A Review and Bibliography, 2nd ed, Odds FC (Ed), Bailliére Tindall, London 1988. p.124.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonçalves B, Ferreira C, Alves CT, et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol 2016; 42:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369:1961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care. J Clin Pharmacol 1992; 32:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vermitsky JP, Self MJ, Chadwick SG, et al. Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol 2008; 46:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bertholf ME, Stafford MJ. Colonization of Candida albicans in vagina, rectum, and mouth. J Fam Pract 1983; 16:919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD, Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996; 34:2497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McClelland RS, Richardson BA, Hassan WM, et al. Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis. J Infect Dis 2009; 199:1883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vitali B, Pugliese C, Biagi E, et al. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol 2007; 73:5731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou X, Westman R, Hickey R, et al. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun 2009; 77:4130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merson-Davies LA, Odds FC, Malet R, et al. Quantification of Candida albicans morphology in vaginal smears. Eur J Obstet Gynecol Reprod Biol 1991; 42:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swidsinski A, Guschin A, Tang Q, et al. Vulvovaginal Candidiasis: Histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. Am J Obstet Gynecol 2018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foxman B. The epidemiology of vulvovaginal candidiasis: risk factors. Am J Public Health 1990; 80:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD. Candida vaginitis. Infect Dis Clin Pract 1994; 3:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donders GG. Lower Genital Tract Infections in Diabetic Women. Curr Infect Dis Rep 2002; 4:536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002; 2:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ray D, Goswami R, Banerjee U, et al. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 2007; 30:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyirjesy P, Zhao Y, Ways K, Usiskin K. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin 2012; 28:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyirjesy P, Sobel JD, Fung A, et al. Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies. Curr Med Res Opin 2014; 30:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilton L, Kollarova M, Heeley E, Shakir S. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 2003; 26:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004; 329:548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duerr A, Heilig CM, Meikle SF, et al. Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity. Obstet Gynecol 2003; 101:548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaeger M, Pinelli M, Borghi M, et al. A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Sci Transl Med 2019; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosentul DC, Delsing CE, Jaeger M, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol 2014; 5:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nedovic B, Posteraro B, Leoncini E, et al. Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta-analysis. Biomed Res Int 2014; 2014:738298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van de Wijgert JH, Verwijs MC, Turner AN, Morrison CS. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS 2013; 27:2141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddad LB, Wall KM, Tote K, et al. Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia. Obstet Gynecol 2019; 134:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Auler ME, Morreira D, Rodrigues FF, et al. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Med Mycol 2010; 48:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cakiroglu Y, Caliskan S, Doger E, et al. Does removal of CU-IUD in patients with biofilm forming candida really maintain regression of clinical symptoms? J Obstet Gynaecol 2015; 35:600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996; 7:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradshaw CS, Morton AN, Garland SM, et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 2005; 106:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed BD, Zazove P, Pierson CL, et al. Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J Womens Health (Larchmt) 2003; 12:979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muzny CA, Rivers CA, Parker CJ, et al. Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: a mixed methods study. Sex Transm Infect 2014; 90:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel DA, Gillespie B, Sobel JD, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: Results of a prospective cohort study. Am J Obstet Gynecol 2004; 190:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heidrich FE, Berg AO, Bergman JJ. Clothing factors and vaginitis. J Fam Pract 1984; 19:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elegbe IA, Elegbe I. Quantitative relationships of Candida albicans infections and dressing patterns in Nigerian women. Am J Public Health 1983; 73:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heng LS, Yatsuya H, Morita S, Sakamoto J. Vaginal douching in Cambodian women: Its prevalence and association with vaginal candidiasis. J Epidemiol 2010; 20:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corsello S, Spinillo A, Osnengo G, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003; 110:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spinillo A, Pizzoli G, Colonna L, et al. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol 1993; 81:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farage M, Bramante M, Otaka Y, Sobel J. Do panty liners promote vulvovaginal candidiasis or urinary tract infections? A review of the scientific evidence. Eur J Obstet Gynecol Reprod Biol 2007; 132:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janković S, Bojović D, Vukadinović D, et al. Risk factors for recurrent vulvovaginal candidiasis. Vojnosanit Pregl 2010; 67:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merenstein D, Hu H, Wang C, et al. Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women. AIDS Res Hum Retroviruses 2013; 29:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereira LC, Correia AF, da Silva ZDL, et al. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Eur J Clin Microbiol Infect Dis 2021; 40:1681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291:1368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckert LO. Clinical practice. Acute vulvovaginitis. N Engl J Med 2006; 355:1244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckert LO, Hawes SE, Stevens CE, et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998; 92:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy. Clin Infect Dis 1997; 24:649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol 2017; 130:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215. Obstet Gynecol 2020; 135:e1. Reaffirmed 2022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           National guideline for the management of vulvovaginal candidiasis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999; 75 Suppl 1:S19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SWARTZ JH, LAMKINS BE. A RAPID, SIMPLE STAIN FOR FUNGI IN SKIN, NAIL SCRAPINGS, AND HAIRS. Arch Dermatol 1964; 89:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobel JD, Subramanian C, Foxman B, et al. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep 2013; 15:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dan M, Leshem Y, Yeshaya A. Performance of a rapid yeast test in detecting Candida spp. in the vagina. Diagn Microbiol Infect Dis 2010; 67:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chatwani AJ, Mehta R, Hassan S, et al. Rapid testing for vaginal yeast detection: A prospective study. Am J Obstet Gynecol 2007; 196:309.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marot-Leblond A, Nail-Billaud S, Pilon F, et al. Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test. J Clin Microbiol 2009; 47:3821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopwood V, Evans EG, Carney JA. Rapid diagnosis of vaginal candidosis by latex particle agglutination. J Clin Pathol 1985; 38:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsui H, Hanaki H, Takahashi K, et al. Rapid detection of vaginal Candida species by newly developed immunochromatography. Clin Vaccine Immunol 2009; 16:1366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abbott J. Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med 1995; 25:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donders GGG, Ravel J, Vitali B, et al. Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice. Gynecol Obstet Invest 2017; 82:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabrizi SN, Pirotta MV, Rudland E, Garland SM. Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics. Mycoses 2006; 49:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diba K, Namaki A, Ayatolahi H, Hanifian H. Rapid identification of drug resistant Candida species causing recurrent vulvovaginal candidiasis. Med Mycol J 2012; 53:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahmoudi Rad M, Zafarghandi ASh, Amel Zabihi M, et al. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol 2012; 2012:872169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weissenbacher T, Witkin SS, Ledger WJ, et al. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Arch Gynecol Obstet 2009; 279:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwebke JR, Gaydos CA, Nyirjesy P, et al. Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis. J Clin Microbiol 2018; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996; 42:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002; 99:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mendling W, Brasch J, German Society for Gynecology and Obstetrics, et al. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mycoses 2012; 55 Suppl 3:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donders GG, Sobel JD. Candida vulvovaginitis: A store with a buttery and a show window. Mycoses 2017; 60:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paavonen J, Brunham RC. Bacterial Vaginosis and Desquamative Inflammatory Vaginitis. N Engl J Med 2018; 379:2246.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5452 Version 67.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Gardella C, Eckert LO, Lentz GM. Genital tract infections. In: Comprehensive Gynecology, 7th ed, Lobo RA, Gershenson DM, Lentz GM, Valea FA (Eds), Elsevier, Philadelphia 2017. p.542.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26042815" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Sexually transmitted diseases treatment guidelines, 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/380743" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Vaginal microbial flora in normal young women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19558525" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: Risk factors and rates of occurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6690835" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7625516" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The epidemiology of vulvovaginal candidiasis among university students.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23486072" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23486072" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26690853" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17560449" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Vulvovaginal candidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1564129" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Evolving pathogens in vulvovaginal candidiasis: Implications for patient care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18305136" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6341500" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Colonization of Candida albicans in vagina, rectum, and mouth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8880507" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19456235" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17644631" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19528218" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Vaginal microbiota of women with frequent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3895958" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9500475" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1778291" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Quantification of Candida albicans morphology in vaginal smears.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Vulvovaginal Candidiasis: Histologic lesions are primarily polymicrobial and invasive and do not contain biofilms
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2305918" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The epidemiology of vulvovaginal candidiasis: risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Candida vaginitis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12433331" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Lower Genital Tract Infections in Diabetic Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11835694" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17259500" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22632452" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24517339" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12825971" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15333452" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12636961" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31189718" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25295030" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25143944" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23660575" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31403592" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20055746" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25496204" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Does removal of CU-IUD in patients with biofilm forming candida really maintain regression of clinical symptoms?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8834559" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Risk factors for vulvovaginal candidiasis: a case-control study among university students.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15994624" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14709186" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24431188" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: a mixed methods study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15041994" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: Results of a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6481318" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Clothing factors and vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6338749" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Quantitative relationships of Candida albicans infections and dressing patterns in Nigerian women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20009371" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Vaginal douching in Cambodian women: Its prevalence and association with vaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12932875" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : An epidemiological survey of vulvovaginal candidiasis in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8469460" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17204360" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Do panty liners promote vulvovaginal candidiasis or urinary tract infections? A review of the scientific evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21061843" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Risk factors for recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23098053" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33713006" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15026404" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Evaluation of vaginal complaints.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16990387" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Clinical practice. Acute vulvovaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9794664" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9145739" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594779" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Clinical Validation of a Test for the Diagnosis of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31856123" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10616376" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : National guideline for the management of vulvovaginal candidiasis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14070843" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : A RAPID, SIMPLE STAIN FOR FUNGI IN SKIN, NAIL SCRAPINGS, AND HAIRS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23354954" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mixed vaginitis-more than coinfection and with therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20226617" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Performance of a rapid yeast test in detecting Candida spp. in the vagina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17403399" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Rapid testing for vaginal yeast detection: A prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19794036" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3988958" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Rapid diagnosis of vaginal candidosis by latex particle agglutination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19656990" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Rapid detection of vaginal Candida species by newly developed immunochromatography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741332" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29017160" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17022774" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23149354" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Rapid identification of drug resistant Candida species causing recurrent vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22791958" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18506464" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29643195" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8656170" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Women's use of over-the-counter antifungal medications for gynecologic symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11864668" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22519657" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27687503" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Candida vulvovaginitis: A store with a buttery and a show window.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30575452" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Bacterial Vaginosis and Desquamative Inflammatory Vaginitis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
